Ingka Group is restructuring its leadership beginning 1 January 2026 to reinforce its focus on the core IKEA Retail business and strengthen its omnichannel strategy. The new Group Management model ...

Fresenius Kabi has launched its denosumab biosimilars Conexxence® and Bomyntra® across Europe following European Commission approval in July 2025 for all indications of their reference medicines ...